Clinical Trial Update: Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial by Iovance Biotherapeutics evaluating autologous tumor-infiltrating lymphocytes in solid tumors is currently recruiting for metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Lifileucel (autologous tumor-infiltrating lymphocytes (TIL) therapy)

Snippet

Sponsor: Iovance Biotherapeutics, Inc. | Conditions: Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: RECRUITING